N@N

30 a.m. ET November 8, 2012 to Discuss Third Quarter 2012 Results

^{Published on 2012-11-01 05:31:27 - Market Wire}
 

Alere Inc. Schedules Conference Call for 8:30 a.m. ET November 8, 2012... -- WALTHAM, Mass., Nov. 1, 2012 /PRNewswire/ --

WALTHAM, Mass., Nov. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: [ ALR ]), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its third quarter 2012 earnings on Thursday, November 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (877) 270-2148 (domestic) or (412) 902-6510 (international) and asking for Alere Inc.  A webcast of the call can also be accessed via the Alere web site at [ www.alere.com/investors ], or directly through the following link: [ http://www.videonewswire.com/event ].

A replay will be available approximately one hour after the conclusion of the call and will remain available for a period of seven days following the call.  The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10020552.  The replay will also be available via online webcast at [ http://www.videonewswire.com/event ] or via the Alere web site at [ www.alere.com/investors ] for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home.  Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology, diabetes, oncology and women's health.  Alere is headquartered in Waltham, Massachusetts. 

For additional information on Alere, please visit [ www.alere.com ]. 

SOURCE Alere Inc.